as on December 19, 2025 at 4:01 pm IST
Day's Low
Day's High
7.35%
Downside
0.98%
Upside
52 Week's Low
52 Week's High
57.51%
Downside
28.74%
Upside
as on December 19, 2025 at 4:01 pm IST
Market Cap
₹15.04 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0.3
P/B Ratio
-22.63
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-106.67
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Venmax Drugs & Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 15.04 | 67.26% | 0.00 | -1 | NA | |
| NA | 1,977.34 | 8.41% | 0.00 | NA | NA | |
| NA | 480.90 | 31.61% | 0.00 | 32 | 151 | |
| NA | 79.57 | -11.47% | 0.00 | 10 | 40 | |
| NA | 1,544.47 | 270.52% | 0.71 | 42 | 362 |
Search interest for Venmax Drugs & Pharmaceuticals Ltd Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Venmax Drugs & Pharmaceuticals Ltd.
Venmax Drugs & Pharmaceuticals Ltd’s net profit jumped 106.67% since last year same period to ₹0.02Cr in the Q2 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -50% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, Venmax Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
![]()
In the last 1 year, Venmax Drugs stock has moved up by 112.8%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 23.14% of holdings in Sep 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 76.87% to 76.87% in Sep 2025 quarter
| Organisation | Venmax Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Venmax Drugs & Pharmaceuticals Ltd share price today stands at ₹28.71 as on at the close of the market. Venmax Drugs & Pharmaceuticals Ltd share today touched a day high of ₹28.99 and a low of ₹26.6.
Venmax Drugs & Pharmaceuticals Ltd touched a 52 week high of ₹36.96 and a 52 week low of ₹12.2. Venmax Drugs & Pharmaceuticals Ltd share price today i.e. is closed at ₹28.71, which is -22.32% down from its 52 week high and 135.33% up from its 52 week low.
Venmax Drugs & Pharmaceuticals Ltd market capitalisation is ₹15.04 Cr as on .
To buy Venmax Drugs & Pharmaceuticals Ltd shares, you need to follow these steps:
Venmax Drugs & Pharmaceuticals Ltd trading volume is 629.00 as on . This means that 629.00 shares of Venmax Drugs & Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.